A detailed history of Central Pacific Bank Trust Division transactions in Abbott Laboratories stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 4,045 shares of ABT stock, worth $463,112. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,045
Previous 3,954 2.3%
Holding current value
$463,112
Previous $411 Million 12.25%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$100.07 - $118.13 $9,106 - $10,749
91 Added 2.3%
4,045 $461 Million
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $35,456 - $39,578
352 Added 9.77%
3,954 $411 Million
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $394,491 - $435,697
3,602 New
3,602 $404 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.